The Clinton Health Access Initiative (CHAI) has received US$25 million in new funding commitments from the Bill & Melinda Gates Foundation and The ELMA Foundation to help nine governments build comprehensive oxygen ecosystems.
Resource type: News and Press Releases
Partners announce reduced price for patient-friendly tuberculosis preventive treatments
MedAccess, Unitaid, The Aurum Institute, and the Clinton Health Access Initiative (CHAI) have announced two new agreements to lower the price of rifapentine-based treatments to prevent tuberculosis in low- and middle-income countries.
New agreement secures historic US$1 price for HIV self-test
MedAccess, the Clinton Health Access Initiative (CHAI), and Wondfo announced an agreement to make Wondfo’s HIV self-test available for US$1 to over 140 countries.
CHAI sessions at AIDS 2022
A full list of sessions that CHAI is participating in at AIDS 2022.
Sweden and Clinton Health Access Initiative partner to invest US$34M to support universal health coverage in Africa
The government of Sweden and CHAI announce a partnership to accelerate progress toward the goals of sexual and reproductive health and human rights and universal health coverage (UHC) in Africa.
Shionogi, GARDP, and CHAI announce landmark license and collaboration agreements to treat bacterial infections by expanding access to cefiderocol in 135 countries
The collaboration agreement includes provisions to work with ministries of health and other experts to strengthen hospital-based stewardship programs that ensure appropriate use. These provisions are especially important to avoid fueling resistance to cefiderocol.
Portable thermal ablation devices allow more women to access lifesaving cervical cancer prevention in countries where the majority of deaths occur
The white paper published today shows that thermal ablation, a portable and effective tool for treating cervical precancer, has the potential to substantially expand access in low- and middle-income countries where almost 90 percent of deaths occur.
FAQ: What you need to know about CHAI’s generic Paxlovid deal
CHAI announced agreements with leading generic manufacturers to make generic Paxlovid available to low- and middle income countries for under US$25 per treatment course.
Press release: CHAI announces agreements with leading generic manufacturers to make affordable COVID-19 treatment available in low- and middle-income countries
New agreements will make generic Paxlovid available at under US$25 per treatment course.
CHAI Board of Directors announces appointment of Dr. Neil Buddy Shah as Chief Executive Officer
As CHAI marks 20 years, Shah adds his expertise to a senior leadership team that has decades of experience tackling health system gaps.